Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€3.62

€3.62

2.890%
0.1
2.890%
€31.90

€31.90

 
22:26 / Tradegate WKN: A3CSM8 / Symbol: TPST / Name: Tempest Therapeutics / Stock / Small Cap /
Latest predictions
20.03.24
10.37%
buy
€43.32
20.03.24
7.74%
buy
€13.96
08.02.24
-9.50%
buy
€12.00
16.10.23
-40.17%
buy
€44.23
11.10.23
103.37%
buy
€31.90
11.08.23
494.87%
buy
Best running prediction
€31.90
11.08.23
494.87%
buy
Your prediction

Tempest Therapeutics Inc. Stock

There is an upward development for Tempest Therapeutics Inc. compared to yesterday, with an increase of €0.10 (2.890%).
With 6 Buy predictions and not the single Sell prediction the community is currently very high on Tempest Therapeutics Inc..
Based on the current price of 3.62 € the target price of 31 € shows a potential of 756.35% for Tempest Therapeutics Inc. which would more than double the current price.
For the coming years our community has positive and negative things to say abot the Tempest Therapeutics Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Valuation (undervalued/overvalued)" there were negative voices in the community.

Pros and Cons of Tempest Therapeutics Inc. in the next few years

Pros
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

It seems that Tempest Therapeutics Inc. experienced a significant decline in its stock price today, which may have led to concerns among investors backpack battles
Show more

Tempest Therapeutics, Inc. (NASDAQ: TPST) had its "outperform" rating re-affirmed by analysts at William Blair.
Ratings data for TPST provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 7.74%
Target price 43.325
Change
Ends at 20.03.25

Tempest Therapeutics, Inc. (NASDAQ: TPST) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $47.00 price target on the stock.
Ratings data for TPST provided by MarketBeat
Show more